Dennis E Mayock, MD

Dennis E Mayock, MD


On staff since March 1985

Academic Title: Professor, Pediatrics

Research Center: Center for Clinical and Translational Research

"My goal is to provide the best evidenced-based medical care to newborns. When evidence is not available on which to base clincal decisions, I feel obligated to pursue such answers through clinical research projects. Generation of new evidence remains my primary focus."

  • Biography

    Dr. Mayock's basic research interests include evaluation of the effects of fetal and neonatal drug (alcohol, morphine) exposure on fetal, neonatal and adult cerebrovascular function. Dr. Mayock's clinical research interests include evaluation of therapies that potentially may improve the outcomes in infants at risk for neurodevelopmental impairment, and treatments that may alter the likehood of developing Bronchopulmonary Dysplasia such as inhaled nitric oxide and late surfactant treatments.

    In collaboration with Drs. Juul and Gleason, he is evaluating whether high dose erythropoietin treatment has neuroprotective effects in preterm and term infants. In collaboration with Dr. Meghan Delaney, he is exploring different methods of protecting infants from transfusion related CMV disease.

  • Patient Testimonials
  • Awards and Honors
    Award Name Award Description Awarded By Award Date
    SEATTLE TOP DOCTOR - 2022 Seattle Magazine 2022
    SEATTLE'S TOP DOCTOR - 2017 Seattle Magazine 2017
    SEATTLE MAGAZINE TOP DOCTOR - 2016 Seattle Magazine 2016
    Seattles Top Doctor 2016 Seattle Met Magazine 2016
    Seattle's Top Doctor Seattle Magazine 2014
    Seattle's Top Doctor Seattle Magazine 2012
    David E. Woodrum Faculty Teaching Award UW Divsion of Neonatology 2012
    U.S. News Top Doctor U.S. News and World Report 2012
  • Publications

    Other Publications

    • Shankaran S, Lin A, Maller-Kesselman J, Zhang H, O'Shea TM, Bada HS, Kaiser JR, Lifton RP, Bauer CR, Ment LR, Gene Targets for Intraventricular Hemorrhage Study
      Maternal race, demography, and health care disparities impact risk for intraventricular hemorrhage in preterm neonates.
      24589078 The Journal of pediatrics, 2014 May : 164(5)1005-1011.e3
    • 57. Vanderhoeven JP, Peterson SE, Gannon EE, Mayock DE, Gammill HS
      Neonatal morbidity occurs despite pulmonary maturity prior to 39 weeks gestation
      Journal of Perinatology, 2014 April : 34(4)322-325
    • Laura R. Ment, Ulrika dn, Aiping Lin, Soo Hyun Kwon, Murim Choi, Mikko Hallman, Richard P. Lifton, Heping Zhang and Charles R. Bauer ; for the Gene Targets for IVH Study Group (Mayock DE- Site Investigator)
      Geneenvironment interactions in severe intraventricular hemorrhage of preterm neonates
      Pediatric Research, 2014 : 75(1)241-250
    • Adén U, Lin A, Carlo W, Leviton A, Murray JC, Hallman M, Lifton RP, Zhang H, Ment LR, Gene Targets for Intraventricular Hemorrhage Study Group
      Candidate gene analysis: severe intraventricular hemorrhage in inborn preterm neonates.
      23896193 The Journal of pediatrics, 2013 Nov. : 163(5)1503-6.e1 PMCID:PMC3812267
    • Aden U, Lin A, Carlow W, Leviton A, Murray JC, Hallman M, Lifton R, Zhang H, Ment LR, on behalf of Gene Targets for Intraventicular Hemorrhage Study Group (Mayock DE -Site Investigator)
      Canadidate Gene Analysis:severe intraventricular hemorrhage in inborn preterm neonates
      23896193 J Periatr, 2013 Jun 25
    • Chabra S, Mayock DE, Zerzan J, Bittner R, Neufeld MD, Gleason CA
      Vitamin A Status After Prophylactic Intramuscular Vitamin A Supplementation in Extremely Low Birth Weight Infants.
      23462416 Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2013 Mar 5
    • Mayock DE, Gleason CA
      Pain and Sedation in the Neonatal ICU.
      NeoReviews, 2013 : 14e22-e31
    • Dennis E. Mayock, MD
      Outcomes of extremely low birth weight infants given early high-dose erythropoietin
      22722674 J Perinatol, 2013 : 33226-230
  • Research Funding
    Grant Title Grantor Amount Award Date
    Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) NINDS 1U01NS077953-01 $10,255,370 2013 - 2018
    Neonatal Erythropoietin and Therapeutic Hypothermia Short-Term Outcome Study (NEAT O Study). Trasher Foundation $7,869 2013 - 2016
    Neonatal CMV infection: a comparative effectiveness study of transfusion safety Department of Pediatrics AEF 2013 - 2015
    Darbe Administration in Newborns Undergoing Cooling for Encephalopathy (DANCE Trial) Trasher Grant $41,994 2012 - 2014
    Gene Targets for IVH NINDS 2010 - 2012
    Phase I Multicenter Clinical Trial of Early High-Dose Erythropoietin in Term Infants with Hypoxic-Ischemic Encephalopathy (NEAT Trial) Thrasher Foundation 2010 - 2013
    U01 (Subcontract to Ballard); NHLBI; Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia (BPD): The TOLSURF Study $155,042 Sep 15, 2009 - Jul 31, 2014


Board Certification(s)

Neonatal-Perinatal Medicine

Medical/Professional School

Ohio State University College of Medicine, Columbus, OH


University of Washington School of Medicine, Seattle, WA

Clinical Interests

Cerebrovascular function in neonates, RSV, Nitric oxide clinical trials